Nxera Pharma reports Q4 results (SOLTF:OTCMKTS)

• Nxera Pharma press release (SOLTF): Q4 Revenue of $197.9M. • R&D expenses totalled JPY 14,466 million (US$96.7 million), an increase of JPY 2,650 …